| | | | | |
| €27,1636 | -0,44% | €240,28M | €5,76K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | €12,0601 | +0,14% | €239,99M | €10,85K | |
TSI TCW Strategic Income Fund, Inc. | €3,7613 | +0,25% | €239,59M | €45,08K | |
PAII Pyrophyte Acquisition Corp. II | €8,8093 | +0,14% | €239,17M | €4,283 | |
| €12,0969 | +0,87% | €239,05M | €50,00K | |
YDES YD Bio Limited Ordinary Shares | €4,0337 | +1,05% | €239,05M | €1,14K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,6028 | +0,53% | €238,75M | €5,11K | |
RWAY Runway Growth Finance Corp. Common Stock | €5,5756 | -0,93% | €238,73M | €14,29K | |
JILL J.Jill, Inc. Common Stock | €16,8913 | -1,45% | €238,72M | €2,74K | |
LCTX Lineage Cell Therapeutics, Inc. | €0,93798 | +0,46% | €238,30M | €149,20K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8,8350 | -0,06% | €238,23M | €6,49K | |
ACV Virtus Diversified Income & Convertible Fund | €22,8070 | +0,62% | €238,21M | €7,44K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,7175 | +0,75% | €238,08M | €52,71K | |
| €1,2035 | +0,36% | €237,99M | €17,69K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | €2,5561 | -0,53% | €237,84M | €7,10K | |
